Dr. Joseph Fuhr Discusses Biosimilar Competition and Trends

Dr. Joseph P. Fuhr, Jr., ACI Senior Fellow and professor of Economics at Widener University, presented at CBI’s 6th Summit on Biosimilars and Follow-On Biologics.  His presentation “A Prospective Look at the Shape of Biosimilar and Innovator Companies in Five to Ten Years,” was presented on Wednesday, March 30, 2011.  His presentation included: An examination of paths […]

Professors Blackstone and Fuhr on the Benefits of Biosimilar Competition

  Benefits from Biosimilar Competition Erwin A. Blackstone and Joseph P. Fuhr, Jr. (For a printable version of this ConsumerGram with its footnotes, please click here biosimilar2-1)   The U.S. is now developing a process for expedited approval of biosimilars. Biopharmaceuticals are far more complex and costly to develop and produce than chemical drugs. Biosimilars […]

Biosimilars and Innovation: Article by Professors Blackstone and Fuhr

Professors Blackstone and Fuhr, both ACI experts, wrote an interesting article on the tradeoff of increased competition vs. increased innovation and the effects on drug prices.   The full citation is: Blackstone, Erwin A. and Fuhr, Joseph P., Jr., “Biosimilars and Innovation: An Analysis of the Possibility of Increased Competition in Biopharmaceuticals,” Future Medicinal Chemistry, vol 2, no. […]